In the News
Sickle cell gene therapy cost-effective if less than $2 million per person
Two models projected fewer pain crisis events with gene therapy over a lifetime, which can offset the high upfront administration costs, study authors wrote.
Testosterone may not decrease fracture risk in hypogonadism
A substudy of an industry-funded randomized trial in men with hypogonadism found that 3.50% of those assigned to testosterone and 2.46% assigned to placebo had a clinical fracture after 3.19 years of follow-up.
MKSAP Quiz: 2-week history of heat intolerance in pregnancy
A 32-year-old woman is evaluated in the first trimester of pregnancy for a 2-week history of heat intolerance, palpitations, and tremulousness. Her only medication is folic acid. Following a physical examination and laboratory studies, what is the most appropriate diagnostic test?
Screening for latent TB may miss higher-risk patients
A study of one large U.S. health system found that risk factors for latent tuberculosis (TB) were not associated with greater likelihood of screening.
Opening keynote speaker announced, precourse registration available
The meeting's Opening Ceremony takes place April 18 in Boston, with precourses on April 16-17.
Correction to ‘ACIP releases 2024 Adult Immunization Schedule featuring new vaccines’
In the Jan. 16, 2024, issue, the article on the 2024 Adult Immunization Schedule incorrectly summarized the recommendations for respiratory syncytial virus (RSV) vaccination.
And the winner is …
I.M. Matters Weekly from ACP has tallied the voting from its latest cartoon contest, where readers are invited to match wits against their peers to provide the most original and amusing caption.